A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection.
about
Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeuticsThe Role of FcRn in Antigen PresentationUnraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based TherapeuticsThe neonatal Fc receptor, FcRn, as a target for drug delivery and therapyThe Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cellsThe role of Fc receptors in HIV infection and vaccine efficacy.Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry.Regulation of immune responses by the neonatal fc receptor and its therapeutic implicationsMonoclonal antibodies directed against human FcRn and their applications.Unique features of antiviral immune system of the vaginal mucosaAntibodies and their receptors: different potential roles in mucosal defense.Neonatal Fc Receptor Regulation of Lung Immunoglobulin and CD103+ Dendritic Cells Confers Transient Susceptibility to Tuberculosis.Antibody-based concepts for multipurpose prevention technologies.Mucosal dendritic cells shape mucosal immunity.CFP10: mFcγ2 as a novel tuberculosis vaccine candidate increases immune response in mouseFc-fusion proteins: new developments and future perspectives.Engineering immunity in the mucosal niche against sexually transmitted infections.The multiple facets of FcRn in immunity.Fcγ1 fragment of IgG1 as a powerful affinity tag in recombinant Fc-fusion proteins: immunological, biochemical and therapeutic properties.Design of cocktail peptide vaccine against Cytomegalovirus infection.Alteration of Polymeric Immunoglobulin Receptor and Neonatal Fc Receptor Expression in the Gut Mucosa of Immunodeficiency Virus-Infected Rhesus Macaques.An HIV Envelope gp120-Fc Fusion Protein Elicits Effector Antibody Responses in Rhesus Macaques.Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization.APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice.A Plant-Derived Multi-HIV Antigen Induces Broad Immune Responses in Orally Immunized Mice.Chicken IgY Fc Linked to Bordetella avium ompA and Taishan Pinus massoniana Pollen Polysaccharide Adjuvant Enhances Macrophage Function and Specific Immune Responses.Multiple mechanisms mediate enhanced immunity generated by mAb-inactivated F. tularensis immunogen.Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6:CFP-10 complex.Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen.Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations.
P2860
Q26822421-D28C022C-6255-4380-A711-36C0E78C6476Q26852988-BE8CC8BD-251C-4319-9CFF-0E50B4539946Q27027238-5E027293-9E38-40DD-BA27-9018CD87E7DCQ28257521-BDC4F13B-5A3A-431A-B755-B750054F6386Q28302792-6DE059D5-D5A9-457F-A106-51CB3976ABE6Q33997395-DEAD6B14-A88C-446E-875D-149DC376BBBFQ34146728-A1982BAC-2446-4334-9652-6A82BEF0E711Q34818194-1F82F80E-7A1D-4CAF-B259-99B336726A4CQ35992498-5F62A3B0-FF65-4651-8178-F768DDE5C808Q36177229-38EC8FA2-FB8B-424B-8211-40D3A8415A89Q37015487-C07D7841-409E-4B11-9341-1134993B7D03Q37287212-A9A7AD41-2C45-428C-A268-F2DB7EE400A0Q37601003-8DD66910-B6D1-4A43-9AF0-21E2E26146AAQ37679445-6C4704CD-DC5E-4813-9C5D-36499899DB31Q37683742-B930B9EC-C1A5-4A0E-816E-1633D01A6812Q38029985-EB442B59-0721-45AA-AEEA-549ECBAA306CQ38543768-23B4219E-0954-496C-BB64-01B9C182A7E1Q38615385-A7AB3593-801B-4799-AFF0-96D627FB5AE7Q38799374-080CA02A-A76F-4E9E-B1FD-82DA88FE7BFBQ38859818-BC1DFA90-D458-4D54-A02A-9C230FFE6FCBQ40010413-9EE6F95B-FF9A-4FEC-9102-B98B34537BACQ40245017-77239144-DFEF-4D88-9F15-FFE50788E7CFQ40344808-7897EA59-04D9-4D47-BADF-634F27CCD9E3Q41355686-83AA9794-0C79-43CE-BA70-77E54030A5F4Q41424896-AACFF77E-258A-4F7A-BE16-12B23BB46D55Q41631517-67EC58CE-3CB2-435C-B32A-7774F7C8040FQ42096393-8BE593AB-0D7C-4C80-AE99-A850C103BD05Q51347966-34CC9A39-F491-4E33-A089-DC42F3C7B922Q51730564-8CB0EDD1-5F33-4D7D-BB89-49C88236FB9CQ52558317-7B0EA5B9-3A95-4266-A6E0-5692BC3B6F91
P2860
A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A neonatal Fc receptor-targete ...... immunity to genital infection.
@ast
A neonatal Fc receptor-targete ...... immunity to genital infection.
@en
type
label
A neonatal Fc receptor-targete ...... immunity to genital infection.
@ast
A neonatal Fc receptor-targete ...... immunity to genital infection.
@en
prefLabel
A neonatal Fc receptor-targete ...... immunity to genital infection.
@ast
A neonatal Fc receptor-targete ...... immunity to genital infection.
@en
P2093
P2860
P356
P1433
P1476
A neonatal Fc receptor-targete ...... immunity to genital infection.
@en
P2093
C David Pauza
Derry C Roopenian
Rongyu Zeng
Senthilkumar Palaniyandi
Xiaoping Zhu
Xindong Liu
Yunsheng Wang
P2860
P304
10542-10553
P356
10.1128/JVI.05441-11
P407
P577
2011-08-17T00:00:00Z